Effects of soy isoflavone aglicone on middle-aged women's health-related quality of life

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: 8‐week treatment with 25 mg of soy isoflavone aglicone 8‐week treatment with 12.5 mg of soy isoflavone aglicone 8‐week treatment with 0 mg of soy isoflavone aglicone CONDITION: menopausal symptoms PRIMARY OUTCOME: health‐related quality of life INCLUSION CRITERIA: women with menopausal symptoms
Epistemonikos ID: 8be656c8e3cfa22cf1485cb0daf34c67fe0e86a2
First added on: Aug 22, 2024